Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06688578 · ClinicalTrials.gov registry record · NA

Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait

A NA study of Aging and Vestibular Disorder, sponsored by Massachusetts Eye and Ear Infirmary.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
2
Study locations

NCT06688578: Recruiting NA study of Aging and Vestibular Disorder, sponsored by Massachusetts Eye and Ear Infirmary.

NCT06688578 is a NA study of Aging and Vestibular Disorder that is actively recruiting participants, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 120 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06688578, a NA study of Aging and Vestibular Disorder, is actively recruiting participants, sponsored by Massachusetts Eye and Ear Infirmary.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
2
Study locations

Study Summary

The goal of this intervention study is to determine if a new electronic stimulation device, similar to a TENS can improve balance and make walking easier in older individuals with reduced balance function. The main question aims to answer the following: Can using the device improve walking speed in older individuals? Participants will be asked to perform a number of tasks while wearing the device: Walk for 6 minutes * Stand in place while having balance measured (eyes open and closed) * Stand on a foam block while having balance measured (eyes open and closed) * Sit in a chair that will tilt +/- 20 degrees while wearing goggles that take videos of the participants eyes.

Primary Outcome

Gait will be measured with a set of motion sensors (Xsens MTw Awinda motion sensors). These wearable inertial monitors measure rotational rate, acceleration, magnetic field strength, and temperature. The sensors are about the size of a watch and attach with Velcro bands. The sensors are wirelessly synchronized with each other and the software, eliminating interconnecting cables and minimizing risk of falling. Gait measures will include gait velocity, gait variability, gait synchronization.

Interventions

  • DEVICE Sham Comparator
  • DEVICE Subperceptual Stimulus

Study Locations (2)

Maryland

  • Johns Hopkins Medicine - Baltimore

Massachusetts

  • Massachusetts Eye and Ear, Harvard Medical School - Boston

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2026-02-25
Est. Completion 2026-05-31
Phase NA

What NCT06688578 shows while recruiting

NCT06688578 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (95% lower).

The record links to 2 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Sham Comparator is the first listed.

NCT06688578 reports a single indexed study location in Maryland, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06688578 about?

NCT06688578 is a clinical study titled "Testing Effectiveness of a Stochastic Noise Stimulator to Immediately Improve Balance and Gait". The goal of this intervention study is to determine if a new electronic stimulation device, similar to a TENS can improve balance and make walking easier in older individuals with reduced balance function. The main question aims to answer the following: Can using the device improve walking speed in...

What is the current status of trial NCT06688578?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2026-02-25. Estimated completion is 2026-05-31.

What conditions does trial NCT06688578 study?

This clinical trial studies the following conditions: Aging, Vestibular Disorder.

What interventions are being tested in trial NCT06688578?

The interventions under investigation include: Sham Comparator (DEVICE), Subperceptual Stimulus (DEVICE).

Who is sponsoring clinical trial NCT06688578?

This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06688578 being conducted?

This trial has 2 study locations across Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06688578's enrollment target sits among peer trials

120 70th of 262 higher than 188 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06688578, the US trial registry maintained by the National Library of Medicine. NCT06688578 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.